Redmile Group, LLC
Filing Date
Global Rank
#1,398
/ 8,592
▲ 152
Top Industry
Biotechnology
98.7%
3Y Alpha vs SPY
-13.9%
Period ended 3 months ago
Filed May 15, 2026 · 35d
25 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+22.5%
SPY
+76.8%
Annualised alpha
-13.9%
Max drawdown
−53.8%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
35 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
29.5%
+12.1 pts
Top 5
66.0%
+5.5 pts
Top 10
81.9%
+2.1 pts
HHI
1,290
Diversified+410
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $1,510,149,025 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
6 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ALXO | Alx Oncology Holdings Inc | +4,699,470 | 7,964,188 | $15,968,196 | |
| ANNX | Annexon, Inc. | +4,499,124 | 14,549,768 | $80,605,714 | |
| SRRK | Scholar Rock Holding Corp | +3,845,775 | 9,066,621 | $445,715,088 | |
| SLDB | Solid Biosciences Inc. | +151,353 | 2,011,895 | $14,485,644 | |
| STOK | Stoke Therapeutics, Inc. | +130,050 | 4,164,120 | $135,583,747 | |
| XENE | Xenon Pharmaceuticals Inc. | +128,792 | 262,674 | $15,274,493 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
16 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| PLRX | Pliant Therapeutics, Inc. | −844,102 | 772,126 | $972,878 | |
| COGT | Cogent Biosciences, Inc. | −749,882 | 688,036 | $26,482,505 | |
| NRIX | Nurix Therapeutics, Inc. | −361,100 | 7,732,808 | $119,858,524 | |
| IDYA | IDEAYA Biosciences, Inc. | −220,900 | 521,117 | $17,363,618 | |
| ADCT | ADC Therapeutics SA | −196,229 | 15,470,502 | $58,014,382 | |
| IMNM | Immunome Inc. | −159,500 | 5,558,885 | $121,572,814 | |
| DBVT | DBV Technologies S.A. | −58,500 | 491,340 | $10,264,092 | |
| CBLL | Ceribell, Inc. | −48,453 | 386,786 | $7,089,787 | |
| BEAM | Beam Therapeutics Inc. | −48,200 | 1,237,659 | $29,493,413 | |
| IVVD | Invivyd, Inc. | −32,500 | 2,648,659 | $3,443,256 | |
| ORIC | Oric Pharmaceuticals, Inc. | −32,400 | 415,710 | $5,267,045 | |
| CLDX | Celldex Therapeutics, Inc. | −21,800 | 261,508 | $8,295,033 | |
| NUVB | Nuvation Bio Inc. | −10,000 | 3,153,256 | $13,527,468 | |
| LIVN | LivaNova PLC | −9,700 | 108,354 | $6,886,980 | |
| ESTA | Establishment Labs Holdings Inc. | −9,200 | 103,464 | $5,874,685 | |
| KRYS | Krystal Biotech, Inc. | −4,200 | 673,505 | $173,979,811 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
5 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| BMRN | Biomarin Pharmaceutical Inc | 173,859 | $9,821,294 | |
| PRME | Prime Medicine, Inc. | 1,590,832 | $5,536,095 | |
| EPRX | Eupraxia Pharmaceuticals Inc. | 700,000 | $5,068,000 | |
| ARDX | Ardelyx, Inc. | 733,350 | $4,392,766 | |
| AGMB | Agomab Therapeutics NV | 156,250 | $1,639,062 | |
| No positions match the current search. | ||||
35 positions ·
$1,510,149,025 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
Added | 9,066,621 | $445,715,088 | 29.51% | |
| KRYS |
Krystal Biotech, Inc.
Healthcare
|
Reduced | 673,505 | $173,979,811 | 11.52% | |
| STOK |
Stoke Therapeutics, Inc.
Healthcare
|
Added | 4,164,120 | $135,583,747 | 8.98% | |
| IMNM |
Immunome Inc.
Healthcare
|
Reduced | 5,558,885 | $121,572,814 | 8.05% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
Reduced | 7,732,808 | $119,858,524 | 7.94% | |
| ANNX |
Annexon, Inc.
Healthcare
|
Added | 14,549,768 | $80,605,714 | 5.34% | |
| ADCT |
ADC Therapeutics SA
Healthcare
|
Reduced | 15,470,502 | $58,014,382 | 3.84% | |
| RGNX |
REGENXBIO Inc.
Healthcare
|
Held | 4,368,804 | $36,610,577 | 2.42% | |
| STTK |
Shattuck Labs, Inc.
Healthcare
|
Held | 5,539,724 | $35,620,425 | 2.36% | |
| BEAM |
Beam Therapeutics Inc.
Healthcare
|
Reduced | 1,237,659 | $29,493,413 | 1.95% | |
| NGNE |
Neurogene Inc.
Healthcare
|
Held | 1,459,599 | $29,425,515 | 1.95% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Reduced | 688,036 | $26,482,505 | 1.75% | |
| ABSI |
Absci Corp
Healthcare
|
Held | 8,253,316 | $24,759,948 | 1.64% | |
| IDYA |
IDEAYA Biosciences, Inc.
Healthcare
|
Reduced | 521,117 | $17,363,618 | 1.15% | |
| ALXO |
Alx Oncology Holdings Inc
Healthcare
|
Added | 7,964,188 | $15,968,196 | 1.06% | |
| FATE |
Fate Therapeutics Inc
Healthcare
|
Held | 12,872,946 | $15,447,535 | 1.02% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Added | 262,674 | $15,274,493 | 1.01% | |
| SLDB |
Solid Biosciences Inc.
Healthcare
|
Added | 2,011,895 | $14,485,644 | 0.96% | |
| NUVB |
Nuvation Bio Inc.
Healthcare
|
Reduced | 3,153,256 | $13,527,468 | 0.90% | |
| ZYME |
Zymeworks Inc.
Healthcare
|
Held | 491,654 | $12,311,016 | 0.82% | |
| SLN |
Silence Therapeutics plc
Healthcare
|
Held | 2,164,777 | $11,408,374 | 0.76% | |
| DBVT |
DBV Technologies S.A.
Healthcare
|
Reduced | 491,340 | $10,264,092 | 0.68% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
NEW | 173,859 | $9,821,294 | 0.65% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Reduced | 261,508 | $8,295,033 | 0.55% | |
| CBLL |
Ceribell, Inc.
Healthcare
|
Reduced | 386,786 | $7,089,787 | 0.47% | |
| LIVN |
LivaNova PLC
Healthcare
|
Reduced | 108,354 | $6,886,980 | 0.46% | |
| ESTA |
Establishment Labs Holdings Inc.
Healthcare
|
Reduced | 103,464 | $5,874,685 | 0.39% | |
| PRME |
Prime Medicine, Inc.
Healthcare
|
NEW | 1,590,832 | $5,536,095 | 0.37% | |
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
Reduced | 415,710 | $5,267,045 | 0.35% | |
| EPRX |
Eupraxia Pharmaceuticals Inc.
Healthcare
|
NEW | 700,000 | $5,068,000 | 0.34% | |
| ARDX |
Ardelyx, Inc.
Healthcare
|
NEW | 733,350 | $4,392,766 | 0.29% | |
| IVVD |
Invivyd, Inc.
Healthcare
|
Reduced | 2,648,659 | $3,443,256 | 0.23% | |
| ATRA |
Atara Biotherapeutics, Inc.
Healthcare
|
Held | 441,701 | $2,089,245 | 0.14% | |
| AGMB |
Agomab Therapeutics NV
Healthcare
|
NEW | 156,250 | $1,639,062 | 0.11% | |
| PLRX |
Pliant Therapeutics, Inc.
Healthcare
|
Reduced | 772,126 | $972,878 | 0.06% |